Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Egy Regulatory News (AURA)

Share Price Information for Aura Egy (AURA)

Share Price is delayed by 15 minutes
Get Live Data
7.00    0.00 (0.00%)
Bid:
6.50
Ask:
7.50
Spread: 1.00 (15.385%)
Market Cap: £71.36m
AURA Live PriceLast checked at - London Stock Exchange

Intraday Aura Egy Share Chart

Appendix 3Y

22 Dec 2022 08:28

RNS Number : 6121K
Aura Energy Limited
22 December 2022
 

22 December 2022

Aura Energy Limited

("Aura" or the "Company")

 

 

Appendix 3Y

 

 

Aura Energy Limited (ASX:AEE, AIM:AURA) ("Aura", the "Company") a company focused on the development of the 85% owned Tiris Uranium Project, Mauritania, advises that an Appendix 3Y (Change of Director's Interest Notice) has been filed with the Australian Securities Exchange ("ASX"). To view the Appendix 3Y please click here: http://www.rns-pdf.londonstockexchange.com/rns/6121K_1-2022-12-22.pdf

 

The Appendix 3Y is also available on the Company's website: https://www.auraenergy.com.au/investor-centre/#asx .

 

 

 

 

For Further Information, please contact:

David Woodall

Managing Director and CEO

Aura Energy Limited

info@auraenergy.com.au

 

Jane Morgan

JMM

Investor & Media Relations

info@janemorganmanagement.com.au

+61 405 555 618

 

SP Angel Corporate Finance LLP

(Nominated Advisor and Joint Broker)

David Hignell

Kasia Brzozowska

+44 (0) 203 470 0470

 

WH Ireland Limited

(Joint Broker)

Jessica Cave

Andrew de Andrade

+44 (0) 207 220 1666

 

 

 

About Aura Energy (ASX:AEE, AIM:AURA)

 

Aura Energy is an Australian-based minerals company with major uranium and polymetallic projects with large resources in Africa and Europe. The Company is principally focused on initial uranium production at its Tiris Uranium Project, an evolving major greenfields uranium discovery in Mauritania, with Aura announcing a Resource Upgrade in August 2021, bringing the total JORC Resource to 56 Mlbs (at a 100 ppm U3O8 lower cut-off grade).

Aura also completed a 2021 capital estimate update for the Tiris Definitive Feasibility Study, to reflect current global pricing, reconfirming Tiris as one of the lowest capex, lowest operating cost uranium projects slated for development.

In October 2021, the Company entered a US$10m Offtake Financing Agreement with Curzon, which includes an additional up to US$10m facility, bringing the maximum available under the agreement to US$20m.

In 2022, Aura will continue to transition from an advanced uranium explorer to uranium producer, to capitalise on the growing appetite for nuclear power as a critical, baseload, near-zero-carbon energy source to help drive the global shift towards decarbonising energy generation.

 
 

 
@AuraEnergyAEE  

 
https://www.linkedin.com/company/aura-energy-limited

Subscribe for Investor Updates

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCTTBPTMTTTMAT
Date   Source Headline
5th Jan 20247:00 amRNSExtensional drilling program at Tiris
4th Jan 202412:07 pmRNSIssue of Equity
4th Jan 202411:56 amRNSTotal Voting Rights
22nd Dec 202310:00 amRNSIssue of Equity
20th Dec 202311:43 amRNSIssue of Equity
12th Dec 20237:26 amRNSIssue of Equity
1st Dec 20238:48 amRNSResults of Annual General Meeting - Addendum
30th Nov 20237:00 amRNSTotal Voting Rights
29th Nov 20238:50 amRNSResult of AGM
29th Nov 20237:00 amRNSNew Tiris Project Tenements Applications
21st Nov 20237:27 amRNSIssue of Equity
16th Nov 20238:20 amRNSIssue of Equity
10th Nov 20237:25 amRNSIssue of Equity
10th Nov 20237:21 amRNSNew Corporate Presentation
3rd Nov 20238:10 amRNSTotal Voting Rights
1st Nov 20237:55 amRNSNew Corporate Presentation
31st Oct 20237:51 amRNSAnnual Report & Notice of Annual General Meeting
30th Oct 20237:49 amRNSQuarterly Report for Period Ending 30 September 23
30th Oct 20237:41 amRNSIssue of Equity
17th Oct 20237:00 amRNSNew Uranium Exploration Target
13th Oct 20238:35 amRNSIssue of Equity
11th Oct 20238:05 amRNSIssue of Equity
4th Oct 20238:26 amRNSTotal Voting Rights
28th Sep 202310:46 amRNSIssue of Equity
26th Sep 202312:26 pmRNSFinancial Report for the year ended 30 June 23
26th Sep 20238:38 amRNSIssue of Equity
21st Sep 20237:24 amRNSIssue of Equity
14th Sep 20237:10 amRNSHolding(s) in Company
12th Sep 20237:00 amRNSChange of Company Secretary
5th Sep 20238:07 amRNSHäggån Scoping Study
31st Aug 20237:00 amRNSChange of share registry address
31st Aug 20237:00 amRNSIssue of Equity
31st Aug 20237:00 amRNSTotal Voting Rights
17th Aug 20237:27 amRNSIssue of Equity
4th Aug 20237:00 amRNSChange of registered office
31st Jul 20237:17 amRNSQuarterly Report for the Period Ending 30 June 23
27th Jul 20237:58 amRNSIssue of Equity
17th Jul 20237:57 amRNSHoldings in Company
30th Jun 20237:00 amRNSTotal Voting Rights
26th Jun 20238:01 amRNSHoldings in Company
20th Jun 20237:00 amRNSSuccessful Share Purchase Plan Completed
9th Jun 20237:00 amRNSShare Purchase Plan offer closing on 13 June 2023
2nd Jun 20237:00 amRNSIssue of Equity
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20237:00 amRNSIssue of Equity
17th May 20237:00 amRNSCleansing Notice
16th May 20237:00 amRNSHoldings in Company
10th May 20237:07 amRNSCleansing Notice
3rd May 20237:18 amRNSA$10 million Placement to Support its Project
2nd May 20237:00 amRNSASX Trading Halt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.